166 results for "Colman, Howard"
Showing 1–20 · 1.04 seconds · RSS
-
Journal Article Full text
Toward more informative biomarker-based clinical trials in glioblastoma
-
Journal Article Full text
IDH1 and IDH2 Mutations in Gliomas
Mutations in isocitrate dehydrogenase (IDH) 1 and 2, originally discovered in 2009, occur in the vast majority of low grade gliomas and secondary high grade gliomas. These mutations, which occur early in gliomagenesis, change the function of the enzymes, causing them to produce 2-hydroxyglutarate…
-
Journal Article Full text
PATH-54. UTILITY OF NEXT GENERATION SEQUENCING IN ADULT PRIMARY BRAIN TUMORS: IMPACT ON DIAGNOSIS AND PERSONALIZED THERAPY
BACKGROUND: Historically, the molecular characterization of gliomas and other brain tumors has been controversial. A diagnosis was primarily made by histological analysis alone, despite concordance among neuropathologists being as low as 52% in some cases. Based on the 2016 World Health…
-
Journal Article Full text
Glioma Subclassifications and Their Clinical Significance
The impact of targeted therapies in glioma has been modest. All the therapies that have demonstrated a significant survival benefit for gliomas in Phase III trials, including radiation, chemotherapy (temozolomide and PCV [procarbazine, lomustine, vincristine]), and tumor-treating fields, are based…
-
Journal Article Full text
THER-07. DEVELOPMENT OF A NEW MOLECULAR PREDICTOR FOR RISK OF BRAIN METASTASES AND EFFICACY OF TARGETED THERAPY IN MELANOMA
Despite therapeutic advances in the treatment of melanoma, development of brain metastases (BM) continues to be a major manifestation of treatment failure. The ability to identify those patients who are at highest risk of developing brain metastases is limited with current methods. Development of…
-
Journal Article Full text
Synaptic Competition during the Reformation of a Neuromuscular Map
We have been studying the mechanisms whereby pools of motor neurons establish a rostrocaudal bias in the position of their synapses in some skeletal muscles. The serratus anterior (SA) muscle of the rat displays a rostrocaudal topographic map before birth, and the topography is re-established after…
-
Journal Article Full text
Challenges of targeting BRAF V600E mutations in adult primary brain tumor patients: a report of two cases
AIM: Therapeutic targeting of BRAF alterations in primary brain tumor patients has demonstrated clinical activity in case reports and early trials; however, there is limited high-level evidence of the efficacy. PATIENTS & RESULTS: Targeting BRAF V600E mutations with concurrent dabrafenib and…
-
Journal Article Full text
QLTI-08. Single institution experience with romiplostim for chemotherapy-induced thrombocytopenia in gliomas
BACKGROUND: Cytotoxic chemotherapy such as temozolomide, lomustine, procarbazine and platinum agents are the mainstay of glioma treatment. These medications cause dose-dependent thrombocytopenia which can lead to chemotherapy dose reductions and delays. Consensus guidelines suggest the…
-
Journal Article Full text
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report
Papillary tumor of the pineal region (PTPR) is a rare brain tumor that probably arises from ependymal cells. There are no known systemic treatments for PTPR once it is refractory to surgery and radiation. We present the first case of a durable radiographic and clinical response of a PTPR to…
-
Journal Article Full text
Cranial and spinal leptomeningeal dissemination in esthesioneuroblastoma: Two reports of distant central nervous system metastasis and rationale for treatment
BACKGROUND: Esthesioneuroblastoma is a locally aggressive cancer of the nasal cavity. While systemic metastasis can occur in 10-30% of patients, there are only six reported cases of distal metastasis from leptomeningeal dissemination. CASE DESCRIPTION: The authors report two cases of…
-
Journal Article Full text
TMOD-19. MUTANT IDH1 PROMOTES GLIOMA FORMATION IN VIVO
Gliomas are the most common primary central nervous system tumor but the molecular mechanisms responsible for their development and progression are not completely understood. Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II-III glioma and secondary glioblastoma (GBM)…
-
Journal Article Full text
First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma
BACKGROUND: Recent advances in targeted therapy and immunotherapy have improved the prognosis of melanoma patients but brain metastasis remains a major challenge. Currently, it is unclear how existing therapies can be best used to prevent or treat brain metastasis in melanoma patients. AIMS: We…
-
Journal Article Full text
NCOG-21. EFFECT OF PNEUMOCYSTIS JIROVECII PNEUMONIA PROPHYLAXIS ON HEMATOLOGIC TOXICITY IN PATIENTS RECEIVING CHEMORADIATION FOR PRIMARY BRAIN TUMORS
INTRODUCTION: Management of diffuse gliomas often includes radiation plus concomitant and adjuvant temozolomide. Hematologic toxicities are common from this therapy. Patients frequently receive prophylaxis against pneumocystis jirovecii pneumonia (PJP) during chemoradiation; however, some PJP…
-
Journal Article Full text
An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah
BACKGROUND: Social determinants of health (SDOHs)—specifically those related to rurality, health care accessibility, and income—may play as-yet-unidentified roles in prognosis for glioma patients, and their impact on access to clinical trials is important to understand. We examined SDOHs of…
-
Journal Article Full text
NIMG-08 EVALUATION OF 2HG MR SPECTROSCOPY IN RELATION TO DISEASE ACTIVITY IN GLIOMAS
-
Journal Article Full text
BIOM-12. ULTRA-DEEP WHOLE GENOME SEQUENCING UNCOVERS A HIGH PREVALENCE OF GLIOBLASTOMA-DERIVED CELL-FREE DNA IN PLASMA
The detection of glioblastoma-derived circulating cell-free DNA (ccfDNA) has proven formidable because tumor-specific mutations are hidden among the abundance of ccfDNA from healthy cells. While capture-enrichment panels provide the necessary read depth to detect low-frequency variants, searches…
-
Journal Article Full text
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments
Advances in molecular genetics have aided the identification of potential biomarkers with significant clinical promise in neurooncology. These advances and the evolution of targeted therapeutics necessitate the development and incorporation of innovative clinical trial designs that can effectively…
-
Journal Article Full text
COMP-10. THE MUTATIONAL PROFILE OF GLIOBLASTOMA-DERIVED CELL-FREE DNA IN PLASMA REPRESENTS A DISTINCT SUBSET OF THE SOMATIC MUTATIONS PRESENT IN GLIOBLASTOMA SOLID TUMOR DNA
Glioblastoma’s mutational landscape varies widely in the same tumor. Using conventional criteria to identify mutations from a focal tissue specimen (e.g., variant allele frequency > 5%) undersamples glioblastoma’s broad clonal diversity, which may limit detection of glioblastoma-derived circulating…
-
Journal Article Full text
HOUT-01. A RETROSPECTIVE ANALYSIS OF OUTCOMES WITH TEMOZOLOMIDE AS INITIAL TREATMENT OF GRADE 2 OLIGODENDROGLIOMA
INTRODUCTION: Prior randomized studies have shown a survival benefit of radiation and chemotherapy compared to radiation alone for grade 2 gliomas (astrocytoma and oligodendroglioma) and grade 3 oligodendroglioma. However, data is mixed regarding outcomes for patients treated initially with…